Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Janux Therapeutics (JANX) Treasury Shares (2024 - 2025)

Historic Treasury Shares for Janux Therapeutics (JANX) over the last 2 years, with Q3 2025 value amounting to $699467.0.

  • Janux Therapeutics' Treasury Shares rose 76823.44% to $699467.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $699467.0, marking a year-over-year increase of 76823.44%. This contributed to the annual value of $341847.0 for FY2024, which is N/A changed from last year.
  • Per Janux Therapeutics' latest filing, its Treasury Shares stood at $699467.0 for Q3 2025, which was up 76823.44% from $701652.0 recorded in Q2 2025.
  • In the past 5 years, Janux Therapeutics' Treasury Shares registered a high of $701652.0 during Q2 2025, and its lowest value of $17500.0 during Q2 2024.